Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology
暂无分享,去创建一个
Ciro Indolfi | C. Indolfi | A. Polimeni | Alberto Polimeni | C. Iaconetti | C. Gareri | Claudio Iaconetti | Clarice Gareri
[1] S. Dimmeler,et al. MicroRNAs in myocardial infarction , 2015, Nature Reviews Cardiology.
[2] Hisashi Adachi,et al. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[3] D. Catalucci,et al. MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts , 2013, PloS one.
[4] Pål Sætrom,et al. Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells , 2013, Circulation research.
[5] T. Capiod,et al. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. , 2013, Cardiovascular research.
[6] L. Zentilin,et al. MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors , 2013, Circulation.
[7] J. Kjems,et al. Natural RNA circles function as efficient microRNA sponges , 2013, Nature.
[8] Sebastian D. Mackowiak,et al. Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.
[9] Howard Y. Chang,et al. Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.
[10] J. Mattick,et al. Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.
[11] Vincent L. Butty,et al. Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment , 2013, Cell.
[12] Manolis Kellis,et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. , 2013, Developmental cell.
[13] C. Indolfi,et al. Vascular miRNAs after balloon angioplasty. , 2013, Trends in cardiovascular medicine.
[14] Yongbo Tang,et al. Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase , 2012, Hypertension.
[15] J. Mattick,et al. Long Noncoding RNAs in Cardiac Development and Pathophysiology , 2012, Circulation research.
[16] Alexander R. Pico,et al. Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage , 2012, Cell.
[17] Nora Engel,et al. The Kcnq1ot1 Long Non-Coding RNA Affects Chromatin Conformation and Expression of Kcnq1, but Does Not Regulate Its Imprinting in the Developing Heart , 2012, PLoS genetics.
[18] Kotb Abdelmohsen,et al. LincRNA-p21 suppresses target mRNA translation. , 2012, Molecular cell.
[19] A. Curcio,et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury , 2012, Basic Research in Cardiology.
[20] P. Antin,et al. Micro-RNA-195 and -451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25 , 2012, PloS one.
[21] G. Owens,et al. Smooth muscle cell phenotypic switching in atherosclerosis. , 2012, Cardiovascular research.
[22] L. Kobzik,et al. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. , 2012, The Journal of clinical investigation.
[23] P. Davies,et al. Site-Specific MicroRNA-92a Regulation of Krüppel-Like Factors 4 and 2 in Atherosusceptible Endothelium , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[24] P. Tsao,et al. MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion , 2012, Science Translational Medicine.
[25] G. Owens,et al. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. , 2012, Annual review of physiology.
[26] L. Zhu,et al. miR-221 is required for endothelial tip cell behaviors during vascular development. , 2012, Developmental cell.
[27] P. Cahan,et al. Polycomb Repressive Complex 2 Regulates Normal Development of the Mouse Heart , 2012, Circulation research.
[28] T. Katsuya,et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. , 2012, Atherosclerosis.
[29] L. Holdt,et al. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[30] Kento Kitada,et al. Pathophysiological roles of endothelin receptors in cardiovascular diseases. , 2012, Journal of pharmacological sciences.
[31] D. Auboeuf,et al. Analysis of co-transcriptional RNA processing by RNA-ChIP assay. , 2012, Methods in molecular biology.
[32] H. Lodish,et al. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. , 2011, Genes & development.
[33] H. Horita,et al. Serum Response Factor Regulates Expression of Phosphatase and Tensin Homolog Through a MicroRNA Network in Vascular Smooth Muscle Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[34] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[35] O. Abdel-Wahab,et al. Faculty Opinions recommendation of lincRNAs act in the circuitry controlling pluripotency and differentiation. , 2011 .
[36] T. Lehtimäki,et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. , 2011, Atherosclerosis.
[37] D. Cacchiarelli,et al. A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.
[38] D. Catalucci,et al. MicroRNA-133 Controls Vascular Smooth Muscle Cell Phenotypic Switch In Vitro and Vascular Remodeling In Vivo , 2011, Circulation research.
[39] M. Goumans,et al. MicroRNA-23 Restricts Cardiac Valve Formation by Inhibiting Has2 and Extracellular Hyaluronic Acid Production , 2011, Circulation research.
[40] Tuck-yun Cheang,et al. MicroRNA-21 Regulates Vascular Smooth Muscle Cell Function via Targeting Tropomyosin 1 in Arteriosclerosis Obliterans of Lower Extremities , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[41] J. Rinn,et al. lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.
[42] Raquel P. Ritchie,et al. Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms. , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[43] B. Davis-Dusenbery,et al. Down-regulation of Krüppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-β and Bone Morphogenetic Protein 4* , 2011, The Journal of Biological Chemistry.
[44] Howard Y. Chang,et al. Extensive and coordinated transcription of noncoding RNAs within cell cycle promoters , 2011, Nature Genetics.
[45] D. Srivastava,et al. Elevated miR-499 Levels Blunt the Cardiac Stress Response , 2011, PloS one.
[46] W. Yuan,et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration , 2011, Heart.
[47] M. Abdellatif,et al. Thioredoxin 1 Negatively Regulates Angiotensin II–Induced Cardiac Hypertrophy Through Upregulation of miR-98/let-7 , 2011, Circulation research.
[48] Leonard Lipovich,et al. Mining Affymetrix microarray data for long non‐coding RNAs: altered expression in the nucleus accumbens of heroin abusers , 2011, Journal of neurochemistry.
[49] Raquel P. Ritchie,et al. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. , 2011, Stem cells and development.
[50] E. Olson,et al. Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.
[51] Mei Han,et al. miR‐146a and Krüppel‐like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation , 2011, EMBO reports.
[52] A. Curcio,et al. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[53] Toshiro K. Ohsumi,et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. , 2010, Molecular cell.
[54] G. Condorelli,et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling , 2010, Nature Cell Biology.
[55] K. Stankunas,et al. VEGF signaling has distinct spatiotemporal roles during heart valve development. , 2010, Developmental biology.
[56] S. Kauppinen,et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. , 2010, The Journal of clinical investigation.
[57] B. Blencowe,et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.
[58] Howard Y. Chang,et al. Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.
[59] Pengyuan Yang,et al. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells , 2010, Journal of hypertension.
[60] M. Gerstein,et al. Annotating non-coding regions of the genome , 2010, Nature Reviews Genetics.
[61] T. Sun,et al. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy , 2010, Journal of Cell Science.
[62] M. Civelek,et al. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro , 2010, Proceedings of the National Academy of Sciences.
[63] G. Milligan,et al. Derivation of Endothelial Cells From Human Embryonic Stem Cells by Directed Differentiation: Analysis of MicroRNA and Angiogenesis In Vitro and In Vivo , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[64] P. Pandolfi,et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.
[65] S. Raguz,et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. , 2010, Molecular cell.
[66] Caroline E. Burns,et al. The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis , 2010, Development.
[67] Y. Suárez,et al. MicroRNAs Are Necessary for Vascular Smooth Muscle Growth, Differentiation, and Function , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[68] Jiang Chang,et al. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. , 2010, American journal of physiology. Heart and circulatory physiology.
[69] J. Rinn,et al. Ab initio reconstruction of transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of lincRNAs , 2010, Nature Biotechnology.
[70] J. Rinn,et al. Ab initio reconstruction of transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of lincRNAs , 2010, Nature biotechnology.
[71] G. Condorelli,et al. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro , 2010, The Journal of cell biology.
[72] Zhe Li,et al. Reciprocal Repression Between MicroRNA-133 and Calcineurin Regulates Cardiac Hypertrophy: A Novel Mechanism for Progressive Cardiac Hypertrophy , 2010, Hypertension.
[73] E. Olson,et al. MicroRNAs add a new dimension to cardiovascular disease. , 2010, Circulation.
[74] G. Schuler,et al. ANRIL Expression Is Associated With Atherosclerosis Risk at Chromosome 9p21 , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[75] B. Long,et al. miR-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy* , 2010, The Journal of Biological Chemistry.
[76] Mei Han,et al. Role of Krüppel‐like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells , 2010, IUBMB life.
[77] Raquel P. Ritchie,et al. miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell Differentiation* , 2010, The Journal of Biological Chemistry.
[78] J. Nerbonne,et al. MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts , 2010, Circulation research.
[79] Stephen A. Stanhope,et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. , 2010, Blood.
[80] D. Catalucci,et al. Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological Conditions , 2009, Circulation.
[81] Stefanie Dimmeler,et al. The microRNA-17~92 cluster: Still a miRacle? , 2009, Cell cycle.
[82] E. Olson,et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. , 2009, Developmental cell.
[83] Ciro Indolfi,et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease , 2009, Cell Death and Differentiation.
[84] A. Lusis,et al. Faculty Opinions recommendation of miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. , 2009 .
[85] Jian-Fu Chen,et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. , 2009, The Journal of clinical investigation.
[86] R. Jaenisch,et al. Loss of Cardiac microRNA-Mediated Regulation Leads to Dilated Cardiomyopathy and Heart Failure , 2009, Circulation research.
[87] Jianqin Jiao,et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy , 2009, Proceedings of the National Academy of Sciences.
[88] Chunxiang Zhang,et al. MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation , 2009, Circulation research.
[89] Chunxiang Zhang,et al. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. , 2009, Journal of molecular and cellular cardiology.
[90] Stefanie Dimmeler,et al. MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.
[91] Yan Sun,et al. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. , 2009, International heart journal.
[92] G. Owens,et al. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. , 2009, American journal of physiology. Heart and circulatory physiology.
[93] G. Nuovo,et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.
[94] J. Mattick,et al. Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.
[95] Yinglin,et al. A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia , 2009 .
[96] Chunxiang Zhang,et al. A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia , 2009, Circulation research.
[97] A. Hata,et al. Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype* , 2009, Journal of Biological Chemistry.
[98] T. Golub,et al. MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes , 2009, Molecular and Cellular Biology.
[99] D. Srivastava,et al. MicroRNAs: Opening a New Vein in Angiogenesis Research , 2009, Science Signaling.
[100] W. Rottbauer,et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.
[101] K. Stankunas,et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 , 2008, Development.
[102] E. Olson,et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. , 2008, Genes & development.
[103] D. Srivastava,et al. microRNA-138 modulates cardiac patterning during embryonic development , 2008, Proceedings of the National Academy of Sciences.
[104] G. Kollias,et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. , 2008, Cell metabolism.
[105] J. Komorowski,et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. , 2008, Molecular cell.
[106] E. Olson,et al. Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.
[107] Scott A Gerber,et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis , 2008, Proceedings of the National Academy of Sciences.
[108] Jeffrey E. Thatcher,et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.
[109] Stefanie Dimmeler,et al. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.
[110] Ru-Fang Yeh,et al. miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.
[111] John McAnally,et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.
[112] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[113] Stefan Lorkowski,et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. , 2008, Human molecular genetics.
[114] Joshua T. Mendell,et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.
[115] A. Hata,et al. SMAD proteins control DROSHA-mediated microRNA maturation , 2008, Nature.
[116] Manching Ku,et al. Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors* , 2007, Journal of Biological Chemistry.
[117] P. Dijke,et al. Extracellular control of TGFβ signalling in vascular development and disease , 2007, Nature Reviews Molecular Cell Biology.
[118] Mahesh P. Gupta,et al. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. , 2007, Journal of molecular and cellular cardiology.
[119] G. Owens. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. , 2007, Novartis Foundation symposium.
[120] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[121] Stefanie Dimmeler,et al. Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.
[122] Howard Y. Chang,et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.
[123] William Stafford Noble,et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.
[124] Chunxiang Zhang,et al. MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.
[125] J. Zavadil,et al. Transforming Growth Factor-β and microRNA:mRNA Regulatory Networks in Epithelial Plasticity , 2007, Cells Tissues Organs.
[126] J. Fish,et al. Hypoxia-inducible Expression of a Natural cis-Antisense Transcript Inhibits Endothelial Nitric-oxide Synthase* , 2007, Journal of Biological Chemistry.
[127] Shuomin Zhu,et al. MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.
[128] E. Edelman,et al. Kruppel-like Factor 4 Regulates Endothelial Inflammation* , 2007, Journal of Biological Chemistry.
[129] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[130] Xiaoxia Qi,et al. Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.
[131] Jordan S. Pober,et al. Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells , 2007, Circulation research.
[132] Jonathan C. Cohen,et al. A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.
[133] Danish Sayed,et al. MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007 .
[134] Danish Sayed,et al. MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.
[135] E. Olson,et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.
[136] Laura Mariani,et al. MicroRNAs modulate the angiogenic properties of HUVECs. , 2006, Blood.
[137] Yusuke Nakamura,et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction , 2006, Journal of Human Genetics.
[138] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[139] Jian-Fu Chen,et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.
[140] Larry A Taber,et al. Biophysical mechanisms of cardiac looping. , 2006, The International journal of developmental biology.
[141] H. Izawa,et al. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway. , 2005, Biochemical and biophysical research communications.
[142] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[143] Jernej Ule,et al. CLIP: a method for identifying protein-RNA interaction sites in living cells. , 2005, Methods.
[144] K. Livak,et al. Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.
[145] P. Oettgen,et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. , 2005, The Journal of clinical investigation.
[146] Yong Zhao,et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.
[147] R. Aharonov,et al. Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.
[148] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[149] S. Scherer,et al. Post-transcriptional Regulation of Endothelial Nitric-oxide Synthase by an Overlapping Antisense mRNA Transcript* , 2004, Journal of Biological Chemistry.
[150] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[151] F. Luscinskas,et al. KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation , 2004, The Journal of experimental medicine.
[152] Hans Peter Luther,et al. Role of endogenous antisense RNA in cardiac gene regulation , 2004, Journal of Molecular Medicine.
[153] P. Weissberg,et al. Krüppel-like Factor 4 (KLF4/GKLF) Is a Target of Bone Morphogenetic Proteins and Transforming Growth Factor β1 in the Regulation of Vascular Smooth Muscle Cell Phenotype* , 2003, The Journal of Biological Chemistry.
[154] A. Curcio,et al. Physical Training Increases eNOS Vascular Expression and Activity and Reduces Restenosis After Balloon Angioplasty or Arterial Stenting in Rats , 2002, Circulation research.
[155] P. Qiu,et al. Histone Acetylation and Recruitment of Serum Responsive Factor and CREB-Binding Protein Onto SM22 Promoter During SM22 Gene Expression , 2002, Circulation research.
[156] C. Indolfi,et al. Membrane-Bound Protein Kinase A Inhibits Smooth Muscle Cell Proliferation In Vitro and In Vivo by Amplifying cAMP–Protein Kinase A Signals , 2001, Circulation research.
[157] S. Klewer,et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.
[158] G. Condorelli,et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo , 1995, Nature Medicine.